Abiopharma

🔍 Lee Carol Young (Executive)

Company: LA-Z-BOY INC (LZB)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 5,766 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 33,155.00 | transaction_form_type: 4
• Sold 224 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 32,931.00 | transaction_form_type: 4
• Sold 309 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 32,622.00 | transaction_form_type: 4
• Acquired 1,142 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 33,764.00 | transaction_form_type: 4
• Sold 279 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 33,485.00 | transaction_form_type: 4
• Acquired 3,166 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 36,651.00 | transaction_form_type: 4
• Sold 771 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 35,880.00 | transaction_form_type: 4
• Acquired 921 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 36,801.00 | transaction_form_type: 4
• Acquired 1,108 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 37,909.00 | transaction_form_type: 4